Nova Patents
AT383852T

Copper chelators for treating ocular inflammation

Abstract

The use of triethylenetetramine (TRIEN) or tetraethylenepentamine (TETREN) to formulate a medicament for the systemic treatment of ocular inflammation.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

14 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
25016400United States of AmericaP

Members14

Family members, oldest first
DocumentOfficeKind
CA2429982A1CanadaA1
WO0243722A2World Intellectual Property Organization (WIPO)A2
AU2141702AAustraliaA
US2003055113A1United States of AmericaA1
WO0243722A3World Intellectual Property Organization (WIPO)A3
EP1370254A2European Patent Office (EPO)A2
US2003232799A1United States of AmericaA1
EP1370254B1European Patent Office (EPO)B1
AT383852TThis recordAustriaT
DE60132494D1GermanyD1
ES2300388T3SpainT3
DE60132494T2GermanyT2
CA2429982CCanadaC
US7754765B2United States of AmericaB2